Lipopolysaccharide Infusion as a Porcine Endotoxemic Shock Model

Summary

We provide a protocol for an experimental endotoxemic shock model in pigs by infusion of lipopolysaccharide.

Abstract

Sepsis and septic shock are frequently encountered in patients treated in intensive care units (ICUs) and are among the leading causes of death in these patients. It is caused by a dysregulated immune response to an infection. Even with optimized treatment, mortality rates remain high, which makes further insights into the pathophysiology and new treatment options necessary. Lipopolysaccharide (LPS) is a component of the cell membrane of gram-negative bacteria, which are often responsible for infections causing sepsis and septic shock.

The severity and high mortality of sepsis and septic shock make standardized experimental studies in humans impossible. Thus, an animal model is needed for further studies. The pig is especially well suited for this purpose as it closely resembles humans in anatomy, physiology, and size.

This protocol provides an experimental model for endotoxemic shock in pigs by LPS infusion. We were able to reliably induce changes frequently observed in septic shock patients, including hemodynamic instability, respiratory failure, and acidosis. This will allow researchers to gain valuable insight into this highly relevant condition and evaluate new therapeutic approaches in an experimental setting.

Introduction

Sepsis and septic shock rank among the leading causes of mortality in patients receiving intensive care treatment^1,2,3. Sepsis arises when an infection triggers a dysregulated immune response resulting in multiorgan failure. It is characterized by life-threatening symptoms, including hemodynamic instability, respiratory distress, hepatic and renal failure, as well as cognitive impairment^4,5. Septic shock represents a subset of sepsis with particularly severe symptoms that significantly increase mortality. These symptoms include persistent hypotension requiring vasopressor therapy and a serum lactate level exceeding 2 mmol∙L^-1 4,5. Mortality rates in patients with septic shock have been estimated as high as 40%, even with hospital treatment^1,3,5.

Gram-negative bacteria, such as Pseudomonas and Escherichia coli, often cause infections triggering this dysregulated immune response⁴. The underlying pathophysiological mechanisms are complex and not yet fully understood. One well-described aspect involves the activation of Toll-like receptors on immune cells by pathogen-associated molecular patterns (PAMPs), leading to the release of cytokines such as tumor necrosis factor-alpha (TNFα) or Interleukin 1 (IL 1)⁴. One of these PAMPs is lipopolysaccharide (LPS), which constitutes a component of the cell membrane in gram-negative bacteria⁶. LPS has been employed in animal models to induce endotoxemia and endotoxemic shock^7,8.

Animal models provide a controlled and standardized setting to develop and investigate novel treatment strategies. Due to its similar anatomy, immunological physiology, and comparable hemodynamic parameters, the pig model is particularly well-suited for studying the effects of endotoxemic shock^9,10. Furthermore, standard medical equipment commonly used in human patients can be readily applied in pigs due to the similar size of their airways and blood vessels, facilitating instrumentation and hemodynamic monitoring.

With this protocol, we provide an experimental model for endotoxemic shock in pigs by intravenously infusing LPS derived from E. coli. To monitor the effects, we measured hemodynamic and pulmonary parameters, including arterial blood pressure, heart rate, peripheral oxygen saturation, pulmonary arterial pressure, and airway pressure. To evaluate the influence of endotoxemia on cerebral oxygen supply, we used near-infrared spectrometry (NIRS). With this method, the cerebral oxygen saturation can be evaluated via an adhesive electrode applied to the forehead¹¹.

Protocol

The experiments in this protocol were approved by the State and Institutional Animal Care Committee (Landesuntersuchungsamt Rheinland-Pfalz, Koblenz, Germany, TVA G21-1-080). The experiments were conducted in accordance with the ARRIVE guidelines. For this study, six healthy male German Landrace pigs aged 2-3 months and weighing 30-35 kg were used. The experimental timeline is summarized in Figure 1. The details related to all materials and instruments used in this protocol are listed in the Table of Materials.

Figure 1: Experimental timeline. Baseline health measurements were taken after the preparation of the animal and a 30 min stabilization period. Endotoxemia was induced by LPS injection over 30 min and 0 h measurements were taken after another 30 min; after that, hourly measurements were continued for 4 h. Abbreviations: BLH = baseline healthy; LPS = lipopolysaccharide. Please click here to view a larger version of this figure.

1. Animal preparation

1. Keep the animals in their usual environment for as long as possible to minimize stress. Withhold food for 6 h prior to the administration of anesthesia, while allowing free access to water.
2. Sedate the animals with an intramuscular injection of azaperone (3 mg∙kg^-1) and midazolam (0.5 mg kg^-1) while still in their normal environment.
3. Once the sedation takes effect, which typically occurs within approximately 15-20 min after administration, transport the pigs to the laboratory.
   NOTE: It is crucial to ensure that continuous sedation is maintained throughout the transfer; depending on the regional legislature, this may require the permanent supervision of a veterinarian.
4. Pay close attention to maintaining the normal body temperature of the pigs (~38 °C) during transport. For instance, consider covering the animal with a blanket to prevent hypothermia.
   NOTE: It is important to limit the transport time to not exceed the duration of sedation, which usually ranges from 30 min to 60 min.
5. Following disinfection, establish an intravenous access by inserting a 22 G catheter in the auricular vein. Before proceeding with any further movement of the pig or induction of anesthesia, ensure that the catheter is securely fixed to prevent dislocation by any sudden movements.
6. Continuously monitor the peripheral oxygen saturation using a sensor clipped to the tail or ear.

2. Anesthesia and mechanical ventilation

1. Administer intravenous fentanyl (4 µg kg^-1) and propofol (3 mg kg^-1) to induce anesthesia.
2. Place the pig in a supine position.
3. Administer atracurium (0.5 mg kg^-1) as a muscle relaxant and immediately initiate non-invasive ventilation using a dog ventilation mask. Place the mask over the snout and apply firm pressure with the thumbs while pulling the lower jaw forward using the middle/ring finger. Set the ventilator to the following parameters: inspiratory oxygen fraction (F_iO₂ ) = 100%, tidal volume = 6-8 mL kg^-1, Positive End Expiratory Pressure (PEEP) = 5 mbar, peak inspiratory pressure ≤ 20 mbar, respiratory rate = 18-20 min^-1.
4. Maintain anesthesia by initiating a continuous infusion of a balanced electrolyte solution (5 mL kg^-1 h^-1), fentanyl (10 µg kg^-1 h^-1), and propofol (6 mg kg^-1 h^-1).
5. Perform endotracheal intubation using a standard endotracheal tube (ID 6-7 mm), a guidewire, and a laryngoscope equipped with a Macintosh Blade (size 4).
   1. Have an assistant open the mouth and hold the tongue to the left side.
   2. Insert the Macintosh Blade until the epiglottis is visible. Then, lift the laryngoscope upwards to move the epiglottis ventrally and visualize the vocal cords. Occasionally, the epiglottis may stick to the soft palate; in this case, mobilize it by gently swiping sideways with the tube or a bougie.
   3. Carefully insert the endotracheal tube through the vocal cords and remove the inducer. If encountering difficulty, try rotating the tube without applying excessive force. If necessary, use a smaller tube. Once the tube is in place, inflate the cuff with 10 mL of air.
6. Connect the endotracheal tube to the ventilator and initiate ventilation. Confirm proper tube positioning by detecting end-expiratory CO₂ and performing bilateral auscultation. Use the following ventilation settings: F_iO₂ = 40%, tidal volume = 6-8 mL kg^-1, PEEP = 5 mbar, inspiration to expiration ratio = 1:2, respiratory rate = adjusted to achieve an end-tidal CO₂ level of <45 mmHg, typically 30-40 min^-1 .
   NOTE: If the tube has been placed incorrectly in the esophagus, air will inflate the stomach, causing a visible bulge. In such cases, immediately remove the tube, administer non-invasive ventilation for 1-2 min, and reposition the tube correctly.
7. Insert a gastric tube to prevent reflux or vomiting. If insertion proves challenging, use the laryngoscope to obtain a better view of the esophageal entrance.

3. Instrumentation

1. Place an arterial and a central venous line in the femoral artery and vein, respectively, for hemodynamic monitoring and intravenous volume therapy.
2. Use bandages to retract and secure the hind legs, providing better access to the femoral vessels.
3. Prepare all necessary materials prior to instrumentation. Fill all catheters with saline solution and ensure easy access to wires and catheters to minimize the need for multiple catheterization attempts and unnecessary blood loss.
4. Apply an alcoholic disinfectant to the inguinal area and wipe it with a sterile swab. Repeat this process twice. Apply the disinfectant again without wiping and wait for 3 min. Place a sterile fenestrated drape over the inguinal area.
5. Use ultrasound to identify the femoral blood vessels. Use an in-plane ultrasound-guided Seldinger's technique for catheterization to minimize tissue damage and blood loss.
6. Visualize the femoral artery longitudinally. Puncture the artery with a syringe attached to the needle for continuous aspiration. Bright red, pulsating blood confirms arterial puncture. Remove the syringe and insert the prepared wire. Remove the needle while leaving the wire in place.
7. Repeat the same procedure for the femoral vein. Venous puncture is confirmed by slow-flowing, dark red blood.
8. Confirm the correct positioning of both wires by visualizing both femoral vessels using ultrasound.
9. Use Seldinger's technique to insert the arterial introducer sheath first, followed by the venous introducer sheath. Confirm proper positioning through blood gas analysis of blood samples drawn from the two lines.
10. Ensure that blood can be aspirated from all lines. Flush all lines with saline solution to prevent clot formation.
11. Securely fix the lines to the skin using surgical sutures to prevent dislocation.
12. Connect the arterial and central venous lines to transducers for the measurement of hemodynamic parameters.
13. Insert a pulse contour cardiac output (PiCCO) catheter into the arterial introducer sheath and connect it to the arterial pressure transducer and temperature interface cable of the PiCCO monitor.
14. Connect a Swan-Ganz catheter to a transducer.
    1. While continuously measuring pressure, insert the catheter into the central venous introducer sheath. Inflate the balloon after approximately 30 cm, when a central venous pressure curve becomes visible.
    2. Slowly advance the catheter while monitoring the pressure curve. As the catheter enters the right ventricle, look for a pulse curve with a high systolic and low diastolic value. Further advancement of the catheter will result in a consistent systolic value and an increased diastolic value, indicating placement in the pulmonary artery.
    3. Fix the catheter in this position (usually between 50 and 70 cm). Connect the injectate temperature sensor of the PiCCO system to the proximal lumen of the Swan-Ganz catheter.
15. Shave the pig's forehead and apply the adhesive sensor electrode to measure Cerebral Regional Oxygen Saturation.
16. After anesthesia induction and instrumentation, allow the animal to stabilize for 30 min or until hemodynamic parameters have stabilized before conducting baseline measurements and inducing endotoxemic shock.

4. Shock induction

NOTE: When working with LPS, always wear gloves, protective goggles, a mask, and a lab coat. Avoid direct contact with LPS.

1. Prepare an LPS solution with a concentration of 100 µg mL^-1 by dissolving 5 mg of LPS in 50 mL of 0.9% NaCl.
2. Obtain baseline hemodynamic measurements immediately before initiating LPS infusion.
3. Administer a 150 µg kg^-1 dose of LPS over 30 min (equivalent to a continuous infusion rate of 300 µg kg^-1∙h^-1 for 30 min).
4. After 30 min, reduce the infusion rate to 15 µg∙kg^-1∙h^-1 for the remainder of the experiment.
5. Continuously monitor hemodynamic parameters, including arterial and pulmonary arterial blood pressure, heart rate, and ventilation parameters. Monitor the body temperature continuously to maintain normothermia.

5. Treatment of hemodynamic instability

1. When the mean arterial blood pressure falls below 60 mmHg, use PiCCO to measure cardiac index (CI), Global End-Diastolic Volume Index (GEDI), and Extravascular Lung Water Index (ELWI). Treat the low blood pressure according to the recommendations in the flow chart in Figure 2.
   1. On the PiCCO monitor, press the thermodilution button (TD).
   2. Press the button for central venous pressure (CVP) input and enter the current CVP value.
   3. Press the Start button.
   4. When instructed to do so, inject 10 mL of cold saline solution into the injectate temperature sensor connected to the Swan-Ganz catheter.
      NOTE: Do not inject anything else directly before or during PiCCO measurement as this would compromise the measurement.
2. After obtaining measurements for CI, GEDI, and ELWI, treat hemodynamic instability according to the flow chart in Figure 2. If Volume loading is recommended, rapidly infuse 200 mL of balanced electrolyte solution. If catecholamine therapy is recommended, increase the rate of norepinephrine infusion by 1 µg kg^-1 h^-1.
3. Repeat this process whenever the mean arterial blood pressure falls below 60 mmHg. In case of severe hemodynamic instability, opt for rapid escalation of therapy.

Figure 2: PiCCO-guided therapy of hemodynamic instability. After obtaining measurements for CI, GEDI, and ELWI, apply treatment according to the chart. This figure was adapted from the PiCCO user guidebook¹². Abbreviations: PiCCO = pulse contour cardiac output; V+ = volume loading; cat = catecholamine therapy; V- = volume reduction; CI = cardiac index; GEDI = global end-diastolic volume index; ELWI = extravascular lung water index. Please click here to view a larger version of this figure.

6. End of experiment and euthanasia

1. Inject 0.5 mg of fentanyl intravenously. Wait 5 min. Inject 200 mg of propofol.
2. Euthanize the pig with a rapid injection of 40 mL of 1 M potassium chloride via the central venous line.

Representative Results

For this study, six healthy male pigs aged 2-3 months and weighing 30-35 kg were anesthetized and received an infusion of lipopolysaccharide (LPS) to induce endotoxemia. To determine the appropriate dosage of LPS required to consistently induce symptoms of shock, the pigs were administered various induction doses of LPS ranging from 100 µg kg^-1 to 200 µg kg^-1 over a 30-min period, followed by a maintenance dose of 1/10 of the initial dose per hour for the remainder of the experiment. All animals exhibited signs of shock shortly after LPS infusion. Hemodynamic parameters were monitored using the PiCCO system. The animals demonstrated a decrease in cardiac index and an increase in heart rate, indicating hemodynamic instability during the shock state. Mean arterial blood pressure decreased following LPS infusion but was maintained above 60 mmHg through fluid resuscitation or norepinephrine infusion if necessary (Figure 3). Lung damage was indicated by a decrease in the PaO₂ F_iO₂^-1 ratio and an increase in pulmonary artery pressure (Figure 4). Cerebral oxygenation was measured using near-infrared spectroscopy (NIRS) and decreased following the induction of shock (Figure 5). The animals also exhibited acidosis and increasing lactate levels (Figure 6). One-way ANOVA with multiple comparisons was used to determine significance.

Figure 3: Development of hemodynamic parameters after LPS infusion. (A) Mean arterial blood pressure decreased after shock induction but was kept over 60 mmHg using norepinephrine infusion if necessary. (B) Cardiac Index was decreased, and (C) heart rate increased after LPS Infusion. Mean and standard deviation are shown. *p < 0.05 compared to baseline measurements. Abbreviations: BLH = baseline health; LPS = lipopolysaccharide. Please click here to view a larger version of this figure.

Figure 4: Development of pulmonary parameters after LPS infusion. (A) The PaO2 FiO2^-1 ratio decreased shortly after LPS Infusion. (B) Driving pressure increased after shock induction. (C) Pulmonary arterial pressure also increased during shock. Mean and standard deviation are shown. *p < 0.05 compared to baseline measurements. Abbreviations: BLH = baseline health; LPS = lipopolysaccharide; F_iO₂ = inspiratory oxygen fraction; PaO2 = partial pressure of oxygen in arterial blood. Please click here to view a larger version of this figure.

Figure 5: Cerebral oxygenation after LPS infusion. Cerebral oxygenation measured via near-infrared spectroscopy decreased after shock induction with LPS. Mean and standard deviation are shown. *p < 0.05 compared to baseline measurements. Abbreviations: BLH = baseline health; LPS = lipopolysaccharide; NIRS = near-infrared spectroscopy. Please click here to view a larger version of this figure.

Figure 6: Arterial blood gas analysis during LPS-induced endotoxemia. (A) The animals became more acidotic over time and (B) lactate levels increased after LPS infusion. Mean and standard deviation are shown. *p < 0.05 compared to baseline measurements. Abbreviations: BLH = baseline health; LPS = lipopolysaccharide. Please click here to view a larger version of this figure.

Discussion

We present a protocol for inducing experimental endotoxemia in pigs through LPS infusion, aiming to reliably induce changes commonly observed in sepsis and septic shock. Several critical steps need to be considered in this protocol. Adequate sedation of pigs prior to transport is crucial to prevent stress-induced elevation of catecholamine levels, which could potentially compromise the results. Intubation of pigs may pose challenges compared to humans due to the anatomical features of their elongated snouts. To address this, we recommend the use of a Macintosh blade for intubation, and the endotracheal tube should be equipped with a straight inducer. It is common for the epiglottis to adhere to the soft palate, and occasionally, a smaller endotracheal tube may be necessary due to the subglottic narrowing of the trachea of the animal so a tube that is able to pass through the vocal cords may still be too large.

Prior to the LPS infusion, precise preparation of the LPS concentration is essential. Administering a higher dose of LPS can result in severe hemodynamic instability and even death, while a lower dose may not produce the desired effects. Additionally, it should be noted that different LPS charges may exhibit varying levels of efficacy. We recommend using the same LPS charge for each trial. Dose-finding trials may be conducted to determine the appropriate dosage for each study. Upon initiation of LPS infusion, continuous monitoring of hemodynamic parameters is crucial due to the potential for rapid instability. Prompt intervention may be necessary to manage any adverse effects.

PiCCO was used for advanced hemodynamic measurements. This technology is also frequently used in human patients treated in the ICU. It was developed for humans and its use in pigs may pose some challenges. Body surface area (BSA) is used for the calculation of hemodynamic parameters. This is calculated automatically when the height and weight of the patient are entered. Although the formula used here (for humans) is not ideal for calculating the BSA of pigs, there is, unfortunately, no other way to enter the BSA. This problem was solved by entering a height of 130 cm for the pigs as in our experience, this yields the most adequate results for BSA. However, this limitation should be kept in mind when interpreting PiCCO results.

Previous studies have described the use of LPS to simulate septic shock in pigs. In these studies, changes frequently observed in septic patients are described such as hypotension, peripheral vasodilation, increased pulmonary arterial pressure, and increased systemic oxygen uptake^13,14,15. Alternative methods for inducing experimental sepsis and septic shock in pigs have also been described. One model involves inducing peritonitis through intraperitoneal administration of feces^16,17,18,19. Another approach is the direct injection of live bacteria into the bloodstream of the animals^19,20. Compared to LPS injection, protocols utilizing peritonitis or bacteremia to induce experimental sepsis offer the advantage of greater realism. These methods induce an actual septic condition through bacterial infection, whereas LPS injection only represents a single aspect of the underlying pathogenetic mechanisms.

However, the LPS infusion method also has its merits. In comparison to the peritonitis model, this protocol requires less effort and expertise as it only involves intravenous injection without the need for intraperitoneal access. Additionally, symptoms of shock manifest more rapidly than in the other models, allowing for shorter observation times and reduced resource utilization. Moreover, the results are highly reproducible since each pig receives the same LPS dosage. In contrast, the composition of administered feces can vary significantly, and bacterial growth is influenced by uncontrollable factors¹⁹.

Despite certain limitations, this protocol consistently induced endotoxemic shock, affecting multiple organ systems. We observed characteristic alterations in lung function and hemodynamics, along with elevated lactate levels in all LPS-treated animals. Due to the continuous deep anesthesia throughout the experiment, we were unable to evaluate cognitive function, which is incorporated into the SOFA score using the Glasgow Coma Scale in humans. However, we did observe a reduction in cerebral oxygenation, suggesting a potential impact of the LPS-induced shock on brain function. In the early stages, sepsis is often associated with a hyperdynamic phase characterized by elevated cardiac output. Because of the rapid progression of symptoms in this model, the data presented here does not adequately show this hyperdynamic phase. If this phase is of particular interest, measurements should be taken more regularly in the early phase of the experiment. An adjustment of the LPS dose may help to slow down the development of symptoms and make it easier to observe the hyperdynamic phase.

LPS and other bacterial endotoxins have previously been employed to simulate sepsis in small animal models⁸. However, using pigs in this context poses certain challenges compared to small animal models like mice. The breeding and maintenance of pigs require considerably more time and effort, and fewer animals can be used per experiment. Nevertheless, large animal models, particularly pigs, provide a more realistic representation of the human body. Pigs exhibit similarities to humans in terms of anatomy, genome, diet, and immune system responsiveness^9,10. Another advantage is the opportunity for repeated blood sample analyses. While small animal models often need specialized equipment, standard medical equipment commonly used in human patients can be applied to pigs, thereby resembling the instrumentation and hemodynamic monitoring in a clinical ICU setting. In conclusion, this protocol establishes an experimental endotoxemia model in pigs through LPS infusion. It offers a simple and standardized method to consistently induce changes frequently observed in septic shock patients.

Materials

Name	Company	Catalog Number	Comments
Atracurium Hikma 50 mg/5mL	Hikma Pharma GmbH, Martinsried
Azaperone (Stresnil) 40 mg/mL	Lilly Deutschland GmbH, Bad Homburg, Germany
BD Discardit II Spritze 2, 5, 10, 20 mL	Becton Dickinson S.A. Carretera, Mequinenza Fraga, Spain	syringe
BD Luer Connecta	Becton Dickinson Infusion Therapy, AB Helsingborg, Schweden	3-way-stopcock
Curafix i.v. classics	Lohmann & Rauscher International GmbH & Co. KG, Rengsdorf, Germany	Cannula retention dressing
Datex Ohmeda S5	GE Healthcare Finland Oy, Helsinki, Finland	hemodynamic monitor
Engström Carestation	GE Heathcare, Madison USA	ventilator
Fentanyl-Janssen 0.05 mg/mL	Janssen-Cilag GmbH, Neuss	fentanyl
Führungsstab, Durchmesser 4.3	Rüsch	endotracheal tube introducer
Incetomat-line 150 cm	Fresenius, Kabi Deutschland, GmbH	perfusor line
Intrafix Primeline	B. Braun Melsungen AG, Melsungen, Germany	Infusion line
Introducer sheath 5 Fr.	Terumo Healthcare	arterial introducer
INVOS	Medtronic, Dublin, Ireland	near infrared spectrometry
JOZA Einmal Nitril Untersuchungshandschuhe	JOZA, München, Germany	disposable gloves
Laryngoscope, 45.48.50, KL 2000	Medicon	Laryngoscope handle
Littmann Classic III Stethoscope	3M Deutschland GmbH, Neuss, Germany	stethoscope
LPS (E. coli; Serotype O111:B4)	Sigma-Aldrich, Switzerland
MAC Two-Lumen Central venous access set	Arrow international inc. Reading, PA, USA	venous introducer
Maimed Vlieskompresse	Maimed GmbH, Neuenkirchen, Germany	Fleece compress to fix the tongue
Masimo LNCS Adtx SpO2 sensor	Masimo Corporation Irvine, Ca 92618 USA	saturation clip for the tail
Masimo LNCS TC-I SpO2 ear clip sensor	Masimo Corporation Irvine, Ca 92618 USA	Saturation clip for the ear
Masimo Radical 7	Masimo Corporation Irvine, Ca 92618 USA	periphereal oxygen saturation
Midazolam 15 mg/3 mL	B.Braun Melsungen AG, Germany
Midmark Canine Mask Small Plastic with Diaphragm FRSCM-0005	Midmark Corp., Dayton, Ohio, USA	dog ventilation mask
Monocryl surgical suture	Johnson & Johnson, Belgium
	B.Braun Melsungen AG, Germany	saline solution
NaCl 0.9 %	Sanofi- Aventis, Seutschland GmbH
Octeniderm farblos	Schülke & Mayr GmbH, Nordenstedt, Germany	Alcoholic disinfectant
Original Perfusor syringe 50 mL	B.Braun Melsungen AG, Germany	perfusor syringe
PA-Katheter Swan Ganz 7.5 Fr 110 cm	Edwards Lifesciences LLC, Irvine CA, USA	Swan-Ganz catheter
Perfusor FM Braun	B.Braun Melsungen AG, Germany	syringe pump
PiCCO catheter	PULSION Medical Systems SE, Feldkirchen, DE
Potassium chloride 1 M	Fresenius, Kabi Germany GmbH
Propofol 2% 20 mg/mL (50 mL flasks)	Fresenius, Kabi Deutschland, GmbH
Pulse-contour continous cardiac output System PiCCO2	PULSION Medical Systems SE, Feldkirchen, DE
Rüschelit Super Safety Clear >ID 6/6.5 /7.0 mm	Teleflex Medical Sdn. Bhd, Malaysia	endotracheal tube
Sonosite Micromaxx Ultrasoundsystem	Sonosite Bothell, WA, USA	ultrasound
Stainless Macintosh Größe 4	Welch Allyn69604	blade for laryngoscope
Sterofundin	B.Braun Melsungen AG, Melsungen, Germany	Balanced electrolyte solution
Vasco OP sensitive	B.Braun Melsungen AG, Germany	sterile gloves
Vasofix Safety 22 G-16 G	B.Braun Melsungen AG, Germany	venous catheter
VBM Cuff Manometer	VBM Medizintechnik GmbH, Sulz a.N., Germany	cuff pressure gauge